The Oxford Biobank is a local Oxfordshire cohort of participants who have given informed consent to be re-approached for further targeted translational studies, such as recall-by-genotype or recall-by-phenotype studies. The Oxford Biobank consists of random healthy participants (n=8000), patients with type 2 diabetes (n=800), and a recently established work place based COVID-19 research cohort.
- Ability to recontact
- Data analytics
- Human functional tissue assays
- Tissue micro array creation
- Nucleic acid extraction
- Obesity (disorder)
|Year||Access Requests Received||Access Requests Approved|